Can a man with benign prostatic hyperplasia and erectile dysfunction safely take tamsulosin together with tadalafil?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 25, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can You Take Tamsulosin with Tadalafil?

No, you should not combine tamsulosin with tadalafil for the treatment of benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS). The American Urological Association explicitly recommends against this combination because it provides no additional symptom improvement over either drug alone while significantly increasing adverse events 1, 2, 3.

Why This Combination Is Not Recommended

Lack of Additional Efficacy

  • The combination of tadalafil 5 mg daily with alpha-blockers (including tamsulosin) does not offer greater symptom improvement compared to monotherapy with either agent alone 1, 2.
  • This recommendation carries Evidence Grade C and is classified as a moderate recommendation by the AUA 2.
  • Multiple systematic reviews confirm that while combination therapy shows statistical improvements in some parameters, the clinical significance does not justify the increased risk of adverse events 1, 4.

Increased Risk of Adverse Events

  • Combining these medications significantly increases the risk of orthostatic hypotension, dizziness, headache, dyspepsia, back pain, and nasal congestion 4, 5.
  • The FDA drug label for tadalafil specifically warns that when taken with alpha-blockers, blood pressure could suddenly drop, potentially causing dizziness or fainting 5.
  • Studies show higher discontinuation rates due to adverse events with combination therapy compared to monotherapy 6, 7.

The Correct Treatment Algorithm

For Men with BOTH BPH/LUTS AND Erectile Dysfunction

  • Choose tadalafil 5 mg once daily as monotherapy 2, 3.
  • Tadalafil simultaneously treats both conditions with a single medication, reducing polypharmacy and enhancing adherence 2.
  • Expected IPSS reduction: -5.4 to -6.1 points versus -3.6 to -3.8 points with placebo 4.
  • Tadalafil also improves erectile function scores (IIEF-EF) while treating urinary symptoms 2.

For Men with BPH/LUTS WITHOUT Erectile Dysfunction

  • Either tadalafil 5 mg daily or tamsulosin 0.4 mg daily are acceptable first-line options 2.
  • Both provide comparable IPSS improvement with no statistically significant difference 2.
  • Choose tamsulosin when absolute contraindications to tadalafil exist (see below) 2.
  • Consider tadalafil when the patient wishes to maintain or improve sexual function 2.

For Men with Acute Urinary Retention

  • Do NOT use tadalafil 3.
  • Initiate an alpha-blocker (tamsulosin 0.4 mg or alfuzosin 10 mg) immediately after catheterization 1, 3.
  • Attempt trial without catheter (TWOC) after at least 3 days of alpha-blocker therapy 1, 3.
  • Success rates: 47% with tamsulosin versus 29% with placebo 1, 3.

Critical Safety Contraindications for Tadalafil

Absolute Contraindications

  • Concurrent use of any nitrate medication (including recreational "poppers" like amyl nitrite or butyl nitrite) due to risk of severe, potentially fatal hypotension 2, 3, 5.
  • Use of guanylate cyclase stimulators (e.g., riociguat/Adempas) 2, 5.
  • Known allergy to tadalafil 5.

Relative Contraindications Requiring Careful Assessment

  • Severe cardiovascular disease (recent MI, stroke, NYHA Class II-IV heart failure) 4, 5.
  • Severe uncontrolled hypertension or hypotension 5.
  • Severe hepatic or renal insufficiency 4, 5.
  • History of NAION (non-arteritic anterior ischemic optic neuropathy) 5.
  • Retinitis pigmentosa 5.

Common Pitfalls to Avoid

Pitfall #1: Assuming Combination Therapy Is Better

  • Despite intuitive appeal, combination therapy does not provide clinically meaningful additional benefit 1, 2.
  • The increased adverse event burden outweighs any marginal statistical improvements 4, 6.

Pitfall #2: Missing Nitrate Use

  • Always screen for nitrate use before prescribing tadalafil, including sublingual nitroglycerin, isosorbide mononitrate/dinitrate, and recreational "poppers" 2, 3, 5.
  • Tadalafil remains in the body for more than 2 days after a single dose, creating prolonged risk 5.

Pitfall #3: Using Tadalafil for Acute Urinary Retention

  • Tadalafil is NOT indicated for acute urinary retention 3.
  • Alpha-blockers are the evidence-based first-line treatment in this emergency setting 1, 3.

Pitfall #4: Inadequate Cardiovascular Assessment

  • Assess cardiovascular fitness before prescribing tadalafil 2, 4.
  • Sexual activity itself places strain on the heart; patients should be counseled to stop activity and seek help if they experience chest pain, dizziness, or nausea during sex 5.

If Already Taking Both Medications

Recommended Action

  • Discontinue one medication based on the patient's primary concern 2, 4:
    • If erectile dysfunction is present: discontinue tamsulosin and continue tadalafil 5 mg daily 2, 4.
    • If erectile dysfunction is absent and cardiovascular contraindications exist: discontinue tadalafil and continue tamsulosin 2.

Evidence for Sequential Therapy

  • Studies show that after discontinuation of either tamsulosin or tadalafil in patients previously on combination therapy, LUTS improvement is preserved compared to baseline 8.
  • However, only tadalafil monotherapy retains erectile function improvement 8.

Dosing Specifications

  • Tadalafil for BPH/LUTS: 5 mg once daily 2, 4.
  • Higher doses have not demonstrated additional urinary symptom benefit 2.
  • Tamsulosin for BPH/LUTS: 0.4 mg once daily 1.
  • Can be titrated to 0.8 mg if needed 1.

Side Effect Profiles

Tamsulosin

  • Orthostatic hypotension (lower risk than other non-selective alpha-blockers) 1.
  • Retrograde ejaculation (higher probability than other alpha-blockers) 1, 2.
  • Dizziness, asthenia, nasal congestion 1.

Tadalafil

  • Headache, dyspepsia, back pain, myalgia 4, 6.
  • Nasal congestion 4, 6.
  • Lower risk of orthostatic hypotension compared to alpha-blockers 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.